Concepedia

Ronald E. Esser

RE

14

Publications

756

Citations

13

H-Index

1985

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Western Laboratories (United States)

University of Missouri

Ronald E. Esser is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and inflammation.

Top concepts

Publications per year

1985–2009

14

Publications

14

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology · 2005 · 123 citations · Full text

, , +17

Cysteine Proteinase Inhibitors Decrease Articular Cartilage and Bone Destruction in Chronic Inflammatory Arthritis

Ronald E. Esser, Richard A. Angelo, Mark D. Murphey et al. · Arthritis & Rheumatism · 1994 · 122 citations

Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2

Jonathan N. King, Janet Dawson, Ronald E. Esser et al. · Journal of Veterinary Pharmacology and Therapeutics · 2009 · 76 citations · Full text

, , +16

Reactivation of streptococcal cell wall‐induced arthritis by homologous and heterologous cell wall polymers

Ronald E. Esser, Stephen A. Stimpson, William J. Cromartie et al. · Arthritis & Rheumatism · 1985 · 74 citations

Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis.

J A Wolos, Kathleen Frondorf, Ronald E. Esser · The Journal of Immunology · 1993 · 57 citations · Full text

, , +20

Rows per page

1–5 of 14